Pacific Biosciences of California (STU:P09) Change In Receivables : €1.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Change In Receivables?

Pacific Biosciences of California's change in receivables for the quarter that ended in Sep. 2024 was €2.7 Mil. It means Pacific Biosciences of California's Accounts Receivable declined by €2.7 Mil from Jun. 2024 to Sep. 2024 .

Pacific Biosciences of California's change in receivables for the fiscal year that ended in Dec. 2023 was €-16.3 Mil. It means Pacific Biosciences of California's Accounts Receivable increased by €16.3 Mil from Dec. 2022 to Dec. 2023 .

Pacific Biosciences of California's Accounts Receivable for the quarter that ended in Sep. 2024 was €26.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pacific Biosciences of California's Days Sales Outstanding for the three months ended in Sep. 2024 was 67.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pacific Biosciences of California's liquidation value for the three months ended in Sep. 2024 was €-424.3 Mil.

Pacific Biosciences of California Change In Receivables Historical Data

The historical data trend for Pacific Biosciences of California's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Change In Receivables Chart

Pacific Biosciences of California Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-6.00

-1.32

-6.34

5.15

-16.35

Pacific Biosciences of California Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-6.05	-5.62	5.79	-1.96	2.75

Pacific Biosciences of California Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.0 Mil.

Pacific Biosciences of California (STU:P09) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pacific Biosciences of California's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	26.474	/	36.01	*	91
=	67.09

2. In Ben Graham's calculation of liquidation value, Pacific Biosciences of California's accounts receivable are only considered to be worth 75% of book value:

Pacific Biosciences of California's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	424.503	-	898.234	+	0.75 * 26.474	+	0.5 * 59.229
=	-424.3

Pacific Biosciences of California Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Biosciences of California Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PACB:USA P09:Germany

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Pacific Biosciences of California Headlines

No Headlines